Skip to main content
Back
Watch Compare

TREACE MEDICAL CONCEPTS, INC.

Data quality: 100%
TMCI
Nasdaq Manufacturing Measuring & Analyzing Instruments
$1.52
▲ $0.12 (8.57%)
Mkt Cap: 98.15 M
Price
$1.52
Mkt Cap
98.15 M
Day Range
$1.32 — $1.55
52-Week Range
$1.17 — $7.78
Volume
458,438
Open $1.37
50D / 200D Avg
$1.75
13.34% below
50D / 200D Avg
$4.34
64.96% below

Quick Summary

Key Takeaways

Revenue grew 22.51% annually over 5 years — strong growth
Negative free cash flow of -29.49 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 20.92%
Capital efficient — spends only 6.36% of revenue on capex

Growth

Revenue Growth (5Y)
22.51%
Above sector avg (9.35%)
Revenue (1Y)1.59%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-63.17%
Below sector avg (-51.02%)
ROIC-26.48%
Net Margin-27.74%
Op. Margin-25.46%

Safety

Debt / Equity
0.62
Above sector avg (0.33)
Current Ratio3.37
Interest Coverage-10.18

Valuation

PE (TTM)
-1.66
Above sector avg (-1.98)
P/B Ratio1.10
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E -1.7 -2.0
P/B 1.1 5.1
ROE % -63.2 -51.0
Net Margin % -27.7 -150.2
Rev Growth 5Y % 22.5 9.3
D/E 0.6 0.3

ETFs Holding This Stock

IWV logo IWV iShares Russell 3000 ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 1.59% Revenue Growth (3Y) 6.61%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 22.51% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 212.69 M Net Income (TTM) -59.00 M
ROE -63.17% ROA -29.28%
Gross Margin 79.81% Operating Margin -25.46%
Net Margin -27.74% Free Cash Flow (TTM) -29.49 M
ROIC -26.48% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.62 Current Ratio 3.37
Interest Coverage -10.18 Asset Turnover 1.06
Working Capital 97.09 M Tangible Book Value 69.01 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.66 Forward P/E N/A
P/B Ratio 1.10 P/S Ratio 0.46
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -30.04%
Market Cap 98.15 M Enterprise Value 145.79 M
Per Share
EPS (Diluted TTM) -0.93 Revenue / Share 3.29
FCF / Share -0.46 OCF / Share -0.25
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 6.36% FCF Conversion 49.98%
SBC-Adj. FCF -63.66 M Growth Momentum -20.92

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 212.69 M 209.36 M 187.12 M 141.84 M 94.42 M
Net Income -59.00 M -55.74 M -49.53 M -42.82 M -20.55 M
EPS (Diluted) -0.93 -0.90 -0.81 -0.77 —
Gross Profit 169.75 M 168.26 M 151.94 M 114.32 M 76.59 M
Operating Income -54.15 M -55.69 M -51.43 M -34.84 M -16.51 M
EBITDA — — — — —
R&D Expenses 20.28 M 20.59 M 15.44 M 13.58 M 10.20 M
SG&A Expenses — — — — —
D&A 10.62 M 8.42 M 5.35 M 2.13 M 685,000.0
Interest Expense 5.32 M 5.26 M 5.17 M 4.40 M 4.06 M
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 190.58 M 217.09 M 251.91 M 159.02 M 140.82 M
Total Liabilities 103.25 M 104.20 M 113.97 M 98.50 M 47.75 M
Shareholders' Equity 87.33 M 112.89 M 137.94 M 60.53 M 93.07 M
Total Debt 57.33 M 53.31 M 53.01 M 52.71 M 29.37 M
Cash & Equivalents 10.71 M 11.35 M 12.98 M 19.47 M 105.83 M
Current Assets 132.05 M 161.40 M 198.36 M 133.40 M 137.97 M
Current Liabilities 30.64 M 34.93 M 45.03 M 30.25 M 18.21 M